Chikungunya Death Risk Factors in Brazil, in 2017: A case-control study

PLoS One. 2022 Apr 7;17(4):e0260939. doi: 10.1371/journal.pone.0260939. eCollection 2022.

Abstract

Background: In 2016/2017 we had a major epidemic of chikungunya (CHIK) in Brazil, with many deaths. We evaluated to factors associated with deaths from CHIK that occurred in the city of Fortaleza, Brazil.

Methods: A matched case-control study was conducted (1:2), by sex, age (± 5 years) and neighborhood. Cases were CHIK deaths that occurred between January 1 and December 31, 2017, in Fortaleza, Brazil, and which were laboratory confirmed. Controls were laboratory confirmed CHIK patients occurring in the same neighborhood and in the same period, but which did not progress to death.

Results: 82 cases of CHIK and 164 controls were included. Considering the clinical history, significant associations were found between other chronic heart diseases (OR 3.8; CI: 1.53-9.26) and chronic kidney disease (OR 12.77; CI: 2.75-59.4). In the multivariate analysis of the variables related to signs and symptoms, fever (OR: 19.23 CI: 1.73-213.78), abdominal pain (OR: 3; 74 CI: 1.06-13.16), apathy (OR: 11.62 CI: 2.95-45.82) and dyspnea (OR: 50.61; CI: 12.37-207.18) were identified with greater likelihood of death from CHIK. It also stood out that altered blood glucose was associated with cases with a worse prognosis (OR: 13.5; CI: 1.3-135.0). Among the laboratory findings, only lymphocytes and albumin were not associated with greater likelihood of death.

Conclusion: The factors related with deaths were chronic kidney disease and previous heart disease, presence of fever, abdominal pain, apathy, dyspnea and arthritis and laboratory findings such as leukocytosis, leukopenia, thrombocytopenia, neutropenia and lymphopenia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdominal Pain
  • Brazil / epidemiology
  • Case-Control Studies
  • Chikungunya Fever* / complications
  • Chikungunya Fever* / diagnosis
  • Chikungunya Fever* / epidemiology
  • Chikungunya virus*
  • Dyspnea
  • Fever
  • Humans
  • Leukopenia*
  • Renal Insufficiency, Chronic*
  • Risk Factors

Grants and funding

This work was partially supported by the Network of Clinical and Applied Research into Chikungunya (REPLICK) through funds from the Department of Science and Technology (DECIT), Brazilian Ministry of Health; by the National Council for Scientific and Technological Development; and by FUNCAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.